Article
Pulmonary arterial hypertension: insights from genetic studies.
Proceedings of the American Thoracic Society - 1 May 2011
Loyd James E
Abstract excerpt
Familial pulmonary arterial hypertension (FPAH) was described 60 years ago, but real progress in understanding its origins and pathogenesis is just beginning. Germline mutations in bone morphogenetic protein receptor type 2 (BMPR2) are responsible for the disease in most families, and also in many sporadic cases of idiopathic PAH. Heritable PAH refers to patients with a positive family history, or with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
